Pyrimidine-mediated regulation of pyrBI operon expression in Escherichia coli K-12 occurs primarily by an attenuation control mechanism. Previous studies have suggested a model for attenuation control in which low intracellular levels of UTP cause close coupling of transcription and translation within the pyrBI leader region. This close coupling apparently prevents transcriptional termination at an attenuator (a p-independent transcriptional terminator) located 23 base pairs before the pyrBI structural genes within an open reading frame for a 44-amino acid leader polypeptide. Presumably, a ribosome involved in the synthesis of the leader polypeptide disrupts or precludes the formation of the attenuator-encoded RNA hairpin, which is required for transcriptional termination. In this study, we examined the role of the ribosome in inhibiting transcriptional termination at the pyrBI attenuator. Using oligonucleotide-directed mutagenesis, we systematically introduced termination codons into the reading frame for the leader polypeptide to determine the distance a ribosome must translate to suppress transcriptional termination. These mutations were incorporated individually into a pyrB::lacZ gene fusion, which was then introduced into the E. coli chromosome. The resulting fusion strains were used to measure the effect of each mutation on pyrB::lacZ expression. The results show that a ribosome must translate to within 14-16 nucleotides of the attenuator-encoded RNA hairpin to inhibit transcriptional termination efficiently, which indicates a direct interaction between the ribosome and the termination hairpin sequence as proposed in the present model. Additional results indicate that factors not included in the present model for attenuation control contribute to the expression and regulation of the pyrBI operon.
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The pyrBI operon of Escherichia coli K-12 encodes the catalytic (pyrB) and regulatory (pyrI) subunits of the pyrimidine biosynthetic enzyme aspartate transcarbamoylase (ATCase; carbamoyl-phosphate:L-aspartate carbamoyltransferase, EC 2.1.3.2). Expression of this operon is negatively regulated over a several hundredfold range by pyrimidine availability. This regulation occurs, at least in large part, by a UTP-sensitive attenuation control mechanism (1, 2) . Previous studies have indicated that transcriptional termination at the pyrBI attenuator, which is a p-independent transcriptional terminator located 23 base pairs (bp) upstream of the pyrB structural gene (see Fig. 1 ), is regulated by the relative rates of transcription and translation within the pyrBI leader region (1, (3) (4) (5) .
According to the present model for attenuation control of pyrBI operon expression, low intracellular levels of UTP cause RNA polymerase to stall at UTP-sensitive pause sites (uridine-rich regions in the leader transcript) preceding the attenuator (see Fig. 1 ). This pausing allows time for a ribosome to initiate translation of a 44-amino acid leader polypeptide and translate up to the stalled RNA polymerase. When RNA polymerase eventually transcribes the attenuator, the adjacent translating ribosome will disrupt or preclude the formation of the attenuator-encoded RNA hairpin, which is necessary for transcriptional termination. The DNA Preparations. Plasmid DNA (1), DNA from phages M13 (1) and A (6), and DNA restriction fragments (1) were prepared as previously described. Oligonucleotides were synthesized using an Applied Biosystems model 380A DNA synthesizer and were purified by gel electrophoresis (1) .
Restriction Digests, Ligations, and Transformations. Restriction digests, ligations, and transformations were performed as previously described (1) .
DNA Sequence Analysis of Oligonucleotide-Directed Mutations. The presence of each ochre mutation introduced into the pyrBI leader region by in vitro oligonucleotide-directed mutagenesis was confirmed by DNA sequence analysis (7) . Single-stranded DNA used as a sequencing template was prepared from the recombinant M13 phage in which the Abbreviations: ATCase, aspartate transcarbamoylase; bp, base pair(s). *To whom reprint requests should be addressed.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. mutation was initially introduced. The sequence of the entire pyrBI promoter-regulatory region (i.e., the sequence shown in Fig. 1 ) was determined in each case to verify that additional changes were not introduced by the mutagenesis procedure.
Transfer ofpyrB::lacZ Gene Fusions from Plasmids to theE. coli Chromosome. The wild-type and mutant pyrB: :lacZ gene fusions constructed in this study and carried on plasmids were individually transferred in single copy to the chromosome of strain CLT42 by using the f6llowing protocol. For each transfer, a transformant of strain CLT42 carrying a pyrB::lacZ fusion plasmid was infected with phage ARZ5 (Fig. 2) , and the resulting lysate was used to transduce strain CLT42 (6) . Ampicillin-resistant (Ap'), Lac+ lysogens were isolated by plating onto LB plates containing ampicillin at 10 lug/ml and 5-bromo-4-chloro-3-indolyl P-D-galactoside (8) .
Phage were prepared from these lysogens (6) and used to reinfect strain CLT42 at a multiplicity of infection of 0.01. The resulting Apr Lac + lysogens were used to prepare phage DNA, which was subjected to restriction enzyme analysis to confirm the presence of the pyrB: :lacZ fusion. The lysogens (at least six isolates) were then screened for the presence of a single copy of the recombinant ARZ5 by measuring the activity of phage-encoded B-galactosidase and ,3-lactamase. The lysogens displaying the lowest enzyme levels were presumed to carry a single prophage. In selected cases, the presence of a single prophage was confirmed by Southern hybridization as described below. All single lysogens constructed in this study had the same 8-lactamase activity.
Test for Single Lysogens by Southern Hybridization. Chromosomal DNA was isolated (9) from a lysogen carrying a recombinant ARZ5 prophage and digested with Pvu I. The digested DNA was prepared for hybridization and probed as described by Maniatis et al. (10) . The radiolabeled probe (11) was the 1313-bp Pst I-Nde I fragment of plasmid pMLB1034 (6) , which contains the promoter-distal end of the bla gene (see Fig. 2 ). Single lysogens showed only a 2.1-kilobase pair band corresponding to a Pvu I fragment that contains phage and chromosomal sequences. Polylysogens had an additional 8.6-kilobase pair band that contains only phage sequences.
Cotransductional Mapping of Recombinant ARZ5 Prophage. Phage P1-mediated cotransductional mapping was used to show the integration of recombinant ARZ5 at the A attachment site in the E. coli chromosome. Phage P1 vir was grown on strain N3030 (gal-76::TnlO), and the resulting lysate was used to transduce a lysogenic derivative of strain CLT42 with selection for tetracycline resistance. Transductants were screened for the loss of A by cross-streaking against A cI and A vir (6) .
Media and Culture Methods. Cells used for enzyme assays were grown in N-C -medium (12) supplemented with 10mM NH4Cl, 0.4% glucose, 0.015 mM thiamine hydrochloride, 1 mM arginine, and either 1 mM uracil or 0.25 mM UMP. Cultures (25 ml in a 125-ml flask) were grown at 30°C with shaking.
Enzyme Assays and Protein Determinations. Cultures were grown to an A650 of 0.5, and 15-ml samples were taken. Cells were collected by centrifugation (4°C), washed with ice-cold 50 mM sodium phosphate (pH 7.0), and stored at -70°C for up to several days without loss of enzymatic activity. Cells were then suspended in 5 ml of 50mM sodium phosphate (pH 7.0) and disrupted by sonic oscillation at 0°C. Extracts were centrifuged at 17,000 x g for 30 min at 4°C to remove cell debris, and the supernatants were used for enzyme and protein assays. ATCase (13), 83-galactosidase (8) , and ,3-lactamase (14) activities were measured as previously de- scribed, except that /3-lactamase assays were done at 30TC. Protein concentrations were measured by the method of Lowry et al. (15) , using crystalline bovine serum albumin as the standard.
RESULTS
Construction of pyrB::lacZ Gene Fusion Plasmids Containing Premature Translational Terminational Codons in the pyrBI Leader Region. The first step in determining the extent of translation required to suppress transcriptional termination at the pyrBI attenuator was to construct a set of pyrB:: lacZ gene fusion plasmids each containing an ochre mutation at a different position in the open reading frame for the pyrBI leader polypeptide (Fig. 1) . The mutations were constructed by in vitro oligonucleotide-directed mutagenesis essentially as previously described (1) . Briefly, each mutation was introduced individually into a recombinant M13 phage that contains a segment of the pyrBI operon. The mutations, which were confirmed by DNA sequence analysis, were excised from replicative form phage DNA as part of a 692-bp Alu I restriction fragment that includes the entire pyrBI promoter-regulatory region and the first 38 codons of the pyrB structural gene (Fig. 1) . Each Alu I fragment was then inserted into the unique Sma I site of plasmid pMLB1034 (6) . Plasmid pMLB1034 contains the E. coli lacZ gene lacking a promoter, a ribosome binding site, and the first eight codons for 3-galactosidase. Recombinant plasmids were isolated in which the Alu I fragment was inserted in an orientation that created an open reading frame joining the pyrB codons to the ninth codon of lacZ. In all constructions the orientation and size of the insert were checked by restriction mapping.
Transfer of the pyrB::lacZ Gene Fusions to the E. coli Chromosome. Before the effect of each ochre mutation on pyrB::lacZ expression was measured, the mutant gene fusions were transferred from the recombinant plasmids to the chromosome of E. coli strain CLT42 [A(argF-lac)U169 car-94]. The transfers were done because previous results (1) had indicated that pyrimidine-mediated regulation of pyrB:: lacZ (or pyrBI) expression is severalfold greater when the gene fusion (or operon) is present as a single, chromosomal copy compared to when it is carried on a multicopy plasmid like pMLB1034. Initially, the gene fusion in each plasmid was transferred to phage ARZ5 by homologous recombination in vivo as described in Fig. 2 and Materials and Methods. The resulting recombinant phage were used to construct single lysogens of strain CLT42. Single lysogens were identified by Southern blotting and by phage-encoded f3-lactamase levels.
They were shown to carry the prophage in the A attachment site by phage P1-mediated cotransductional mapping.
An additional single lysogen of strain CLT42 that carries a wild-type pyrB::lacZ gene fusion was constructed as described above. This strain was made using a previously constructed plasmid, pBHM19 (1), in which the 692-bp Alu I fragment of the wild-type pyrBI promoter-regulatory region has been inserted into plasmid pMLB1034.
Effect of Premature Translational Termination in the pyrBI Leader Region on pyrB::lacZ Expression. The effect of the ochre mutations on pyrB::lacZ expression was determined by measuring the levels of ATCase catalytic subunit/,B-galactosidase fusion protein synthesis in the single lysogens (Table   1) . The strains, which are pyrimidine auxotrophs because the car-94 mutation inactivates a pyrimidine biosynthetic enzyme, were grown in a glucose-minimal salts medium containing either uracil or UMP as the pyrimidine source. Growth on uracil causes repressed pyr gene expression, whereas growth on UMP, which is only slowly utilized by the cells, results in derepressed expression. In the strains carrying an ochre mutation at codon 6, 14, 23, or 24, pyrB::lacZ expression was strongly inhibited. Fusion protein synthesis was reduced to 13-22% of the wild-type level under repressing conditions and 4-6% of the wild-type level under derepressing conditions (Fig. 3) . The 26, 27, 29, or 33, the levels of pyrB::IacZ expression were much closer to that in the wild-type fusion strain. Under repressing conditions, fusion protein synthesis steadily increased from 31% to 123% of the wild-type level as the ochre mutation was moved downstream from codon 25 through codon 33. Under derepressing conditions, fusion protein synthesis was 50-91% of the wild-type level (Fig. 3) . In four of these five strains, pyrimidine-mediated regulation was similar to that in the wild-type strain. possible reason for this large reduction in pyrB: :lacZ expression is discussed below.
In the strains carrying an ochre mutation at codon 6, 14, 23, or 24, the level of pyrimidine-mediated regulation of pyrB:: lacZ expression (i.e., the fold derepression) was reduced to a much lesser extent than the level of fusion protein synthesis (Table 1 ). This result suggests that some read-through translation may be occurring at the ochre codons. To test this possibility, we constructed, exactly as described above, a lysogen that carries an ochre mutation at codon 6 and at codon 14. Fusion protein synthesis in this double mutation strain was measured, and it was found to be essentially identical to that in the lysogen that carries a single ochre mutation at codon 6 (Table 1 ). This result indicates that in-frame read-through translation does not contribute to the observed residual regulation.
In addition to fusion protein levels, the levels of ATCase encoded by the intact chromosomal pyrBI operon of each lysogen were measured in the experiments summarized in The general effect of moving the site of translational termination downstream in the leader transcript from codon 25 through codon 33 is to increase pyrB::lacZ expression. Apparently, the further downstream the ribosome is permitted to translate, the more effective it is at disrupting the attenuator-encoded hairpin. In the strain carrying an ochre mutation at codon 33, which is in the middle ofthe attenuatorencoded sequence (Fig. 1) , expression was actually slightly higher than that in the wild-type strain under repressing conditions and only 9% less than the wild-type level under derepressing conditions. Based on the data shown in Fig. 3 , however, there clearly are other factors in addition to the position of the translating ribosome that affect the level of pyrB: :lacZ expression in the mutant strains. There is a small but reproducible decrease in the level of fusion protein synthesis under derepressing conditions when the ochre mutation is moved from codon 25 to either codon 26 or codon 27. This result suggests that in addition to causing premature translational termination, the introduction of an ochre mutation can change some other property ofthe leader transcript (e.g., transcript stability or potential to form secondary structures) that influences the level ofpyrB: :lacZ expression. Based on recent studies (K. Mayne, J. Donahue, and C.L.T., unpublished data), it is unlikely that any of the ochre mutations would significantly affect UTP-sensitive transcriptional pausing.
The most unexpected result in this study was the low level ofpyrB::lacZ expression in strain CLT5012, which carries an ochre mutation at codon 40. The presence of an ochre mutation at this position in the leader transcript would allow a ribosome to translate through the entire attenuator-encoded sequence exactly as occurs in the wild-type strain. However, fusion protein synthesis in strain CLT5012 was reduced to 29% of the wild-type level under derepressing conditions, which is much less than that in any other strain with an ochre mutation downstream of codon 24. This large reduction in the level of expression indicates that the mutation at codon 40 interferes with an important step in the expression of the read-through transcript. One possible explanation for this effect is that the mutation results in a large reduction in the half-life of the transcript. The ochre mutation at codon 40 changes two bases within a region of the leader transcript that is complementary to the ribosome binding site for the leader polypeptide. It has been suggested that these two comple-mentary sequences form a secondary structure in the pyrBI mRNA that prevents multiple rounds of leader polypeptide synthesis (20) . The formation of this secondary structure may also protect the mRNA from nucleolytic degradation (21) . The destabilization of this secondary structure by the mutational change at codon 40 could therefore make the pyrB:: lacZ transcript more susceptible to degradation, which would decrease the level of fusion protein synthesis. Clearly more experiments are needed to test this hypothesis as well as other possible explanations for the low level of expression in strain CLT5012.
The substantial residual regulation of pyrB::lacZ expression observed in the strains carrying an ochre mutation early in the leader region (e.g., at codon 6) (Table 1) indicates that some pyrimidine-mediated control can occur in the absence of translation of the open reading frame encoding the 44-amino acid leader polypeptide. The residual regulation does not appear to be due to in-frame read-through translation past the ochre mutations. Recent experiments have shown that part of the residual regulation (approximately 6-fold) is due to an as yet uncharacterized, attenuator-independent control mechanism (C.L. and C.L.T., unpublished data). The remainder of the residual regulation, however, appears to be attenuator-dependent. A possible mechanism for this regulation is translation of the leader region in a different reading frame than that of the 44-amino acid leader polypeptide. The leader region does in fact contain a second long open reading frame (bp 97 through bp 243 in Fig. 1 In addition to elucidating the mechanism controlling pyrBI expression in E. coli, the results discussed above provide important information about the proposed control mechanisms for the E. coli pyrE gene (22) and the pyrBI operon of Salmonella typhimurium (23) . In both cases, regulation of gene expression apparently occurs through UTP-sensitive attenuation control mechanisms that are essentially the same as that described for the E. coli pyrBI operon. The major difference in the three mechanisms is the site of translational termination within the leader region. Translation is terminated five nucleotides upstream of the attenuator-encoded sequence in the case of the pyrE gene and within the attenuator-encoded sequence of the S. typhimurium pyrBI operon (at a position equivalent to codon 34 in Fig. 1 ). Based on the data presented here, the sites of translational termination in all three leader regions are essentially equivalent in that they all would allow a translating ribosome to disrupt the signal for transcriptional termination at the respective attenuators.
